Back
EAPC Premium Access

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Discussion

Session: Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)
Topic: Risk Factors and Prevention
Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

Like

7 more presentations in this session

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction

Speaker: Mr G. Neif Vieira Musse (Sao Paulo, BR)

Access
Video
Like
Thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - Commentary

Speaker: Professor M. Minicucci (Botucatu, BR)

Access
Video
Like
Thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - discussion

Access
Like
Thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

Speaker: Doctor C. Ballantyne (Houston, US)

Access
Video
Like
Thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.

Speaker: Professor U. Landmesser (Berlin, DE)

Access
Like
Thumbnail

Access the full session

Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)

Speakers: Mr G. Neif Vieira Musse, Professor M. Minicucci, Doctor C. Ballantyne, Professor U. Landmesser
Access
Video
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources